[1]
A. Tan-Garcia, L. Mun Wang, J. Chi-Yong Ngu, and L. Goh, “Complete pathologic response (pCR) following neoadjuvant pembrolizumab monotherapy in treatment-naive locally advanced, mismatch repair protein-deficient (dMMR) colonic cancer: a case report and literature review”, AO, vol. 61, no. 6, pp. 780–784, Jun. 2022.